Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The D-alanyl-D-alanine terminus of peptidoglycan precursor units is a highly conserved dipeptide that constitutes the terminal amino acids of the peptide sidechain in the nascent peptidoglycan subunits (often on a MurNAc sugar via a pentapeptide stem). This terminus serves as the primary substrate for bacterial transpeptidase enzymes (penicillin-binding proteins) that catalyze the crosslinking of peptidoglycan strands, an essential step in bacterial cell wall biosynthesis[2][3][4][5]. Glycopeptide antibiotics such as vancomycin target this terminus by forming stable non-covalent interactions, thereby preventing proper cell wall assembly, which is lethal to bacteria. Bacterial resistance often develops via substitution of the D-alanyl-D-alanine terminus with alternative structures such as D-alanyl-D-lactate, which reduces antibiotic binding and confers resistance[1][8]. This target is critical for the mechanism of several clinically important antibiotics and is a major determinant in the efficacy and resistance profile of these agents.
Glycopeptide antibiotics (e.g., vancomycin) bind to the D-alanyl-D-alanine terminus, sterically blocking the action of transpeptidase and transglycosylase enzymes, thus inhibiting crosslinking and elongation of the peptidoglycan, leading to bactericidal cell death[1][8].
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on D-alanyl-D-alanine terminus of peptidoglycan precursor unit.